AUS
NZ
UK
CA
USA
IND
Healthcare
GSK Achieves Success in mRNA Flu Vaccine Trial
September 12, 2024 10:50 AM BST| By Team Kalkine MediaGSK PLC,(LSE:GSK),has reported promising results for its mRNA-based seasonal flu vaccine. The company has advanced this vaccine to phase III trials following positive outcomes in phase II testing. This comes on the heels of less favorable news regard...
_08_30_2024_15_24_26_992096.jpg)
Renishaw (LSE:RSW): Steady growth in analytical instruments and medical devices balances flat performance in manufacturing technologies
September 12, 2024 08:51 AM BST| By Team Kalkine MediaRenishaw plc (LSE:RSW) has reported its financial results for the year ended 30 June 2024, delivering record revenue of £691.3 million, slightly up from £688.6 million in FY2023. The company’s revenue growth, though modest at 0.4%, was bolstered by a...
Celadon Pharmaceuticals Shares Fall 20% After Discounted Fundraiser
September 11, 2024 12:45 PM BST| By Team Kalkine MediaShares of Celadon Pharmaceuticals PLC,(LSE: CEL),fell by 20% following the announcement of a £1.05 million equity fundraising round, which involved issuing new shares at a discounted rate.,The company, which specializes in cannabis-based medicines, h...
ANGLE Technology Establishes New Benchmark in Cancer Diagnostics
September 11, 2024 11:47 AM BST| By Team Kalkine MediaANGLE PLC,(LSE:AGL),has received high praise from German investment bank Berenberg, which has reaffirmed its 'buy' recommendation and 70p price target for the company. Currently, ANGLE’s shares are trading at 11.28p.,Berenberg’s note highlights ANGLE...
Arecor Receives Positive Review, Price Target Maintained
September 11, 2024 11:40 AM BST| By Team Kalkine MediaPanmure Liberum has reaffirmed its positive rating and ambitious price target for shares in Arecor Therapeutics PLC,(LSE:AREC),following the company’s announcement of data presentation from a Phase I trial of its fast-acting insulin, AT278, at a majo...
Futura Medical: Investment Bank Affirms Performance Matches Claims
September 11, 2024 11:34 AM BST| By Team Kalkine Media"Doing what it says on the tube" was the headline from a Panmure Liberum report following Futura Medical PLC's,(LSE:FUM),interim results.,The report highlighted a significant achievement for Futura Medical, which has developed a fast-acting erectile...
Arecor Therapeutics Presents Promising Data at Madrid Conference
September 11, 2024 08:54 AM BST| By Team Kalkine MediaArecor Therapeutics PLC,(LSE:AREC),will present positive Phase I trial results for its ultra-concentrated, ultra-rapid-acting insulin, AT278, at the European Association for the Study of Diabetes (EASD) 2024 conference in Madrid. The trial, which inc...
AstraZeneca Shares Slide After Lung Cancer Trial Update
September 10, 2024 12:35 PM BST| By Team Kalkine MediaThe share price of AstraZeneca,(LSE: AZN),experienced a significant decline on Tuesday following disappointing updates from the company's latest lung cancer trials. The stock fell 4.2% to 12,182p by 11:49 BST, having previously dropped by as much as...
CVS Group Shares Rise Despite Intrinsic Value Gap
September 10, 2024 10:47 AM BST| By Team Kalkine MediaCVS Group plc, operating within the,healthcare sector,, has recently experienced a notable increase in its share price, rising over 10% on the AIM market in the past few months. Despite this positive movement, the company's stock has traded at higher...
Futura Posts Early Maiden Profit, Revenue and Earnings to Surge
September 10, 2024 09:44 AM BST| By Team Kalkine MediaFutura Medical PLC,(LSE:FUM),has announced a significant milestone in its financial performance for the first half of 2024, marking its first profit of £1 million on revenues of £7 million. The company closed the period with a strong balance sheet, h...
Futura Medical Hits Milestone with First Profit, Prepares for US Eroxon Launch
September 10, 2024 09:42 AM BST| By Team Kalkine MediaFutura Medical PLC (LSE:FUM) CEO James Barder recently discussed the company's latest financial performance and future outlook with Proactive's Stephen Gunnion. Barder highlighted that Futura Medical has raised its guidance for both profit and revenu...
hVIVO CEO Highlights Record H1 Revenue and Strategic Expansion
September 10, 2024 09:17 AM BST| By Team Kalkine MediahVIVO PLC,(LSE:HVO),CEO Yamin (Mo) Khan recently discussed the company’s notable achievements in the first half of 2024 with Proactive's Stephen Gunnion. During this period, hVIVO reported a 31% increase in revenue, reaching £35.6 million. Khan highl...
ImmuPharma reports interim progress on lead asset
September 09, 2024 07:41 PM BST| By Team Kalkine MediaImmuPharma PLC,(LSE:IMM),has reported progress in developing treatments for autoimmune diseases, with a focus on Systemic Lupus Erythematosus (SLE) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). In its recent update accompanying its in...
Hutchmed to Present New and Updated Clinical Trial Data
September 09, 2024 01:27 PM BST| By Team Kalkine MediaHutchmed China,(LSE:HCM),has announced that it will present new and updated clinical trial data at two major oncology conferences: the 2024 World Conference on Lung Cancer (WCLC24) in San Diego and the European Society for Medical Oncology (ESMO) Con...
RUA Life Sciences Acquires French Implantable Devices Company
September 09, 2024 12:10 PM BST| By Team Kalkine MediaRUA Life Sciences,(LSE:RUA),has completed the acquisition of implantable devices manufacturer Analytic Biosurgical Solutions for €80,000. The purchase was made from the French liquidator of IPSA SAS, the former parent company of Analytic Biosurgical...
Oncimmune Shares Surge Following Contract Wins
September 09, 2024 11:32 AM BST| By Team Kalkine MediaShares in Oncimmune, a company specializing in autoantibody profiling, saw a significant rise on Monday after the firm reported strong commercial progress since its last update in May.,Oncimmune announced that it had secured a major new project with...
Hemogenyx Pharmaceuticals Reaches Critical Milestone
September 09, 2024 07:50 AM BST| By Team Kalkine MediaA prominent player of,Healthcare Sector,Hemogenyx Pharmaceuticals PLC has announced the successful development of a clinical-grade assay designed to measure FLT3 protein levels in acute myeloid leukaemia (AML) cells. This assay is a crucial component...
GSK Reports Positive Results from COPD Trial
September 06, 2024 11:54 AM BST| By Team Kalkine MediaOn Friday, GSK,(LSE:GSK),reported positive results from its phase three ‘MATINEE’ clinical trial, which assessed the efficacy of ‘Nucala’ (mepolizumab) in treating chronic obstructive pulmonary disease (COPD). The FTSE 100 pharmaceutical company reve...
GSK Reports Positive COPD Trial Results
September 06, 2024 08:47 AM BST| By Team Kalkine MediaSuccessful MATINEE Trial Results,GSK PLC,(LSE:GSK),has announced encouraging results from the Phase III clinical trial named MATINEE, which assessed the efficacy of Nucala (mepolizumab) in treating chronic obstructive pulmonary disease (COPD). The tr...
-Copy_09_04_2024_16_34_00_022161.jpg)
Indivior’s CUD Study Falls Short of Primary and Secondary Endpoints
September 04, 2024 05:29 PM BST| By Team Kalkine MediaOn Wednesday, Indivior,(LSE:INDV),reported that the Phase 2B clinical trial conducted by Aelis Farma on the drug AEF0117 for treating cannabis use disorder (CUD) did not achieve its primary and secondary endpoints. The trial was designed with two key...
